Home » Topics » Regulatory » Patents

Patents
RSS

Merck & Co. divulges dual Toll-like receptor 7/8 agonists

Dec. 30, 2021

New psychosine receptor modulators patented by Pathios Therapeutics

Dec. 30, 2021

GB005 discovers Bruton tyrosine kinase inhibitors

Dec. 30, 2021

New transcriptional enhancer factor (TEAD) inhibitors identified at the Dana-Farber Cancer Institute

Dec. 30, 2021

NeoPhore patents DNA mismatch repair protein Mlh1/mismatch repair endonuclease PMS2 inhibitors

Dec. 30, 2021

Roche identifies new antibacterials

Dec. 29, 2021

TOPADUR Pharma identifies dual PDE5A inhibitors/soluble guanylate cyclase activators

Dec. 29, 2021

New USP30 inhibitors identified at Mission Therapeutics

Dec. 29, 2021

New RIPK1 inhibitors discovered at Sanofi

Dec. 29, 2021

Boehringer Ingelheim, Vanderbilt University describe mutant GTPase KRAS inhibitors

Dec. 29, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...